First-line treatment of patients with advanced or metastatic squamous non-small cell lung cancer: systematic review and network meta-analysis | Zendy

Lisa M. Hess | Zendy; Amy M. DeLozier | Zendy; Fanni Natanegara | Zendy; Xiaofei Wang | Zendy; Victoria Soldatenkova | Zendy; Alan Brnabic | Zendy; Stephen L. Able | Zendy; Jacqueline Brown | Zendy

Open Access

First-line treatment of patients with advanced or metastatic squamous non-small cell lung cancer: systematic review and network meta-analysis

Author(s) -

Lisa M. Hess,

Amy M. DeLozier,

Fanni Natanegara,

Xiaofei Wang,

Victoria Soldatenkova,

Alan Brnabic,

Stephen L. Able,

Jacqueline Brown

Publication year - 2018

Publication title -

journal of thoracic disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.682

H-Index - 60

eISSN - 2077-6624

pISSN - 2072-1439

DOI - 10.21037/jtd.2018.11.87

Subject(s) - medicine , meta analysis , oncology , squamous cell cancer , lung cancer , squamous cell carcinoma of the lung , basal cell , first line , cancer

The objectives of this systematic review and meta-analysis were to compare the survival, toxicity, and quality of life of patients treated with necitumumab in combination with gemcitabine and cisplatin. These agents were investigated in published randomized controlled trials (RCTs) of patients with squamous non-small cell lung cancer (NSCLC) in the first-line setting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research